-
Mashup Score: 0BMI outdated for measuring childhood obesity, Bristol study says - 16 hour(s) ago
Researchers who have studied thousands of children suggest a new measure could be more accurate.
Source: www.bbc.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 7
Neil Floch, MD, Director of Bariatric Surgery at Greenwich Hospital explains how well bariatric surgery can work in fighting obesity. FOX61’s Tim Lammers rep…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More - 5 day(s) ago
On March 07, 2024, Novo Nordisk provided updates on semaglutide 2.4 mg as well as the development programs cagrisema, monlunabant, and amycretin.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 10
Groups including Legal & General among those pushing for stricter health targets at world’s biggest food company
Source: www.ft.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Ozempic Is a Brain Drug - 7 day(s) ago
Health The weight-loss effects of GLP-1 drugs have little to do with the gut. March 05, 2024 When scientists first created the class of drugs that includes Ozempic, they told a tidy story about how the medications would work: The gut releases a hormone called GLP-1 that signals you’re full, so a drug that mimics GLP-1 could do the exact same thing, helping people eat less and lose weight. The rest, as they say, is history. The GLP-1 revolution birthed semaglutide, which became Ozempic and Wegovy
Source: apple.newsCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8A frenzy of innovation in obesity drugs is under way - 9 day(s) ago
Novo Nordisk and Eli Lilly are printing money now. But they will not be a stagnant duopoly
Source: www.economist.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More - 11 day(s) ago
On March 07, 2024, Novo Nordisk provided updates on semaglutide 2.4 mg as well as the development programs cagrisema, monlunabant, and amycretin.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 20The obesity capitals of the world - 14 day(s) ago
A new study shows that waistlines are widening almost everywhere
Source: www.economist.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 160One in eight people are now living with obesity - 15 day(s) ago
New study released by the Lancet shows that, in 2022, more than 1 billion people in the world are now living with obesity. Malnutrition, in all its forms, includes undernutrition, inadequate vitamins or minerals, overweight and obesity. Undernutrition is responsible for half of the deaths of children under 5 and obesity can cause noncommunicable diseases such as cardiovascular diseases, diabetes and some cancers.
Source: www.who.intCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 160One in eight people are now living with obesity - 15 day(s) ago
New study released by the Lancet shows that, in 2022, more than 1 billion people in the world are now living with obesity. Malnutrition, in all its forms, includes undernutrition, inadequate vitamins or minerals, overweight and obesity. Undernutrition is responsible for half of the deaths of children under 5 and obesity can cause noncommunicable diseases such as cardiovascular diseases, diabetes and some cancers.
Source: www.who.intCategories: General Medicine News, General HCPsTweet
.@TheEndoSociety member Andrew O. Agbaje, MD, talks to BBC about a new approach to diagnosing childhood #obesity: https://t.co/0sN6BGnjul